A

Avalon Globocare Corp
NASDAQ:ALBT

Watchlist Manager
Avalon Globocare Corp
NASDAQ:ALBT
Watchlist
Price: 1.24 USD -0.8%
Market Cap: 5.3m USD

Avalon Globocare Corp
Investor Relations

Avalon GloboCare Corp. is a holding company, which engages in the development of biotechnology and the provision of healthcare services. The company is headquartered in Freehold, New Jersey and currently employs 5 full-time employees. The company went IPO on 2016-02-22. The firm is focused on the fields of cellular immunotherapy, including CAR-T/NK; exosome technology (ACTEX), and COVID-19-related vaccine and therapeutics through its subsidiaries. The company operates through two business segments: real property operating segment and medical related consulting services segment. The firm also provides strategic advisory and outsourcing services to facilitate and improve its clients’ growth and development, as well as competitiveness in healthcare and CellTech industry markets. Its downstream medical team and facility consists of affiliated hospital networks and experts specialized in hematology, oncology, cellular immunotherapy, hematopoietic stem/progenitor cell transplant, as well as regenerative therapeutics. Its clinical programs include AVA-001, ACTEX, FLASH-CAR, and AVA-Trap.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Dr. David K. Jin M.D., Ph.D.
CEO, President & Director
No Bio Available
Ms. Luisa Ingargiola
Chief Financial Officer
No Bio Available
Ms. Meng Li
COO & Secretary
No Bio Available

Contacts

Address
NEW JERSEY
Freehold
4400 US Highway 9 Ste 3100
Contacts